These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Is combination therapy with inhaled anticholinergics and beta2-adrenoceptor agonists justified for chronic obstructive pulmonary disease? Reddy CB; Kanner RE Drugs Aging; 2007; 24(8):615-28. PubMed ID: 17702532 [TBL] [Abstract][Full Text] [Related]
5. The short, the long and the "ultra-long": why duration of bronchodilator action matters in chronic obstructive pulmonary disease. Beeh KM; Beier J Adv Ther; 2010 Mar; 27(3):150-9. PubMed ID: 20411368 [TBL] [Abstract][Full Text] [Related]
6. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD. Ohar JA; Donohue JF Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301 [TBL] [Abstract][Full Text] [Related]
7. Optimizing maintenance therapy for chronic obstructive pulmonary disease: strategies for improving patient-centered outcomes. Hanania NA Clin Ther; 2007 Oct; 29(10):2121-33. PubMed ID: 18042470 [TBL] [Abstract][Full Text] [Related]
9. [Combinations of bronchodilators in COPD therapy--"fashionable" or rule?]. Mihălţan F Pneumologia; 2013; 62(3):172-5. PubMed ID: 24274002 [TBL] [Abstract][Full Text] [Related]
10. What is in the guidelines about the pharmacological treatment of chronic obstructive pulmonary disease? López-Campos JL; Calero Acuña C Expert Rev Respir Med; 2013 Apr; 7(2 Suppl):43-51. PubMed ID: 23551023 [TBL] [Abstract][Full Text] [Related]
11. [COPD treatment by drugs]. Nafti S Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S58-10S60. PubMed ID: 17127967 [No Abstract] [Full Text] [Related]
12. Bronchodilator combination therapy for the treatment of chronic obstructive pulmonary disease. Sethi S; Cote C Curr Clin Pharmacol; 2011 Feb; 6(1):48-61. PubMed ID: 21235463 [TBL] [Abstract][Full Text] [Related]
13. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study. Boscia JA; Pudi KK; Zvarich MT; Sanford L; Siederer SK; Crim C Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766 [TBL] [Abstract][Full Text] [Related]
14. Impact of tiotropium on the course of moderate-to-very severe chronic obstructive pulmonary disease: the UPLIFT trial. Tashkin DP Expert Rev Respir Med; 2010 Jun; 4(3):279-89. PubMed ID: 20524910 [TBL] [Abstract][Full Text] [Related]
16. Indacaterol 75 μg once daily for the treatment of patients with chronic obstructive pulmonary disease: a North American perspective. Kerwin EM; Williams J Ther Adv Respir Dis; 2013 Feb; 7(1):25-37. PubMed ID: 23296242 [TBL] [Abstract][Full Text] [Related]
20. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Qaseem A; Wilt TJ; Weinberger SE; Hanania NA; Criner G; van der Molen T; Marciniuk DD; Denberg T; Schünemann H; Wedzicha W; MacDonald R; Shekelle P; ; ; ; Ann Intern Med; 2011 Aug; 155(3):179-91. PubMed ID: 21810710 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]